SOPHARMA AD: Notification for acquisition of own shares

opublikowano: 2019-01-02 12:57

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Current_report_180_buy_back_21122018_espi.pdf (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		180	/	2018
	Date of issue:		2019-12-21
	Short name of the issuer
	SOPHARMA AD
	Subject
	Notification for acquisition of own shares
	Official market - legal basis
	art. 56. 1. 2 of Act on Public Offering.
	Unofficial market - legal basis
	Contents of the report:
	Sopharma AD notifies that on December 21, 2018 the Company bought 3 500 own shares representing 0.0026% of the share capital of the Company, at a total value of 12 425.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.55 BGN. The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from February 23, 2018. The total number of treasury shares after this transaction is 8 881 336, representing 6.59% of the share capital of the Company.
	Annexes
	File				Description
	Current report 180 buy back 21122018 espi.pdfCurrent report 180 buy back 21122018 espi.pdf				Notification for acquisition of own shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2019-01-02	Ognian Donev	Executive director